Julien Guiraud, PhD, is currently the Founder & President of Vergio and a Research journal reviewer for Addiction and Addiction Biology. Prior to this, Guiraud served as the CEO of D&A Pharma, overseeing a team of 30 employees and defining CNS drug development strategies. Additionally, Guiraud has experience as a Chief Financial Officer and Manager at KPMG, where Julien was in charge of auditing Airbus Group. Guiraud holds a PhD in Psychiatry from the University of Amsterdam, a Specialized Master's degree in Audit from HEC Paris, and an Engineer's degree in Aeronautical from ISAE-SUPAERO.
Sign up to view 0 direct reports
Get started
This person is not in any teams